Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pheochromocytoma
|
186 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.830 | 0.667 | 3 | 2010 | 2015 | |||||
Familial medullary thyroid carcinoma
|
45 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.810 | 1.000 | 21 | 1993 | 2007 | |||||
Multiple Endocrine Neoplasia Type 2a
|
44 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.810 | 0.929 | 14 | 1993 | 2013 | |||||
Medullary carcinoma of thyroid
|
71 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.750 | 0.833 | 6 | 2005 | 2015 | |||||
Hirschsprung Disease
|
162 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.720 | 1.000 | 2 | 2009 | 2013 | |||||
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1
|
52 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.700 | 1.000 | 15 | 1994 | 2011 | |||||
Multiple Endocrine Neoplasia Type 1
|
156 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.700 | 1.000 | 1 | 2005 | 2005 | |||||
Multiple Endocrine Neoplasia Type 2b
|
21 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.700 | 1.000 | 1 | 2005 | 2005 | |||||
Multiple Endocrine Neoplasia, Type IV
|
23 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.700 | 1.000 | 1 | 2005 | 2005 | |||||
Breast Cancer, Familial
|
91 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.700 | 0 | ||||||||
Malignant neoplasm of breast
|
3417 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.700 | 0 | ||||||||
Adrenal Gland Pheochromocytoma
|
50 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.030 | 0.667 | 3 | 2010 | 2015 | |||||
Hyperparathyroidism, Primary
|
39 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.020 | 1.000 | 2 | 2005 | 2005 | |||||
Glioblastoma Multiforme
|
186 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Malignant neoplasm of stomach
|
615 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Malignant Neoplasms
|
1641 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1 | 2013 | 2013 | ||||||
Multiple endocrine neoplasia Type 2
|
38 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1 | 2013 | 2013 | ||||||
Paraganglioma
|
36 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Pheochromocytoma, malignant
|
1 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Primary malignant neoplasm
|
1374 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1 | 2013 | 2013 | ||||||
Stomach Carcinoma
|
652 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Thyroid carcinoma
|
145 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||
Von Hippel-Lindau Syndrome
|
187 | 0.672 | 0.280 | 10 | 43118460 | missense variant | A/G;T | snv | 4.0E-06; 2.1E-03 | 0.010 | 1.000 | 1 | 2010 | 2010 |